Vaxcyte, Inc. (PCVX) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts PCVX Hot Sheet
Join SI Premium – FREE
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.97), $0.07 better than the analyst estimate of ($2.04).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Avio (AVIO:IM) at Hold
- MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
- Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
